• SmartestCrowd
    • No organizations
    • No projects
0
0
Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb - Yahoo Finance
+ 103 more
12/7/22 at 12:00pm
Organization
Yahoo Entertainment
Author
Prometheus Biosciences
63 words
0
Comments
– ARTEMIS-UC trial met primary endpoint with 26.5% of patients on PRA023 achieving clinical remission compared to 1.5% of patients on placebo at Week 12 (p...
You are the first to view
https://finance.yahoo.com/news/prometheus-biosciences-announces-positive-results-120000364.html
Create an account or login to join the discussion